Biomarkers for Heart Failure: An Update for Practitioners of Internal Medicine

Nicholas Wettersten, Alan S. Maisel

Research output: Contribution to journalReview article

22 Citations (Scopus)

Abstract

Biomarkers have become an integral part of practicing medicine, especially in heart failure. The natriuretic peptides are commonly used in the evaluation of heart failure, but their role extends beyond diagnosis and includes risk stratification and management of heart failure patients. Newer biomarkers have arrived and are becoming part of routine care of heart failure patients. Both ST2 and high-sensitivity troponin have significant prognostic value for mortality, but also may assist in the titration of medical therapy. Procalcitonin can help guide appropriate antibiotic use in patients with heart failure. The ability to appropriately use and interpret these biomarkers is imperative to the care of heart failure patients, especially as these newer biomarkers become widely used.

Original languageEnglish (US)
Pages (from-to)560-567
Number of pages8
JournalAmerican Journal of Medicine
Volume129
Issue number6
DOIs
StatePublished - Jun 1 2016

Fingerprint

Internal Medicine
Heart Failure
Biomarkers
Natriuretic Peptides
Troponin
Risk Management
Calcitonin
Medicine
Anti-Bacterial Agents
Mortality

Keywords

  • Biomarkers
  • BNP
  • Heart failure
  • Procalcitonin
  • ST2
  • Troponin

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Biomarkers for Heart Failure : An Update for Practitioners of Internal Medicine. / Wettersten, Nicholas; Maisel, Alan S.

In: American Journal of Medicine, Vol. 129, No. 6, 01.06.2016, p. 560-567.

Research output: Contribution to journalReview article

Wettersten, Nicholas ; Maisel, Alan S. / Biomarkers for Heart Failure : An Update for Practitioners of Internal Medicine. In: American Journal of Medicine. 2016 ; Vol. 129, No. 6. pp. 560-567.
@article{d3bf2d9901a942cfa805de98ac445f06,
title = "Biomarkers for Heart Failure: An Update for Practitioners of Internal Medicine",
abstract = "Biomarkers have become an integral part of practicing medicine, especially in heart failure. The natriuretic peptides are commonly used in the evaluation of heart failure, but their role extends beyond diagnosis and includes risk stratification and management of heart failure patients. Newer biomarkers have arrived and are becoming part of routine care of heart failure patients. Both ST2 and high-sensitivity troponin have significant prognostic value for mortality, but also may assist in the titration of medical therapy. Procalcitonin can help guide appropriate antibiotic use in patients with heart failure. The ability to appropriately use and interpret these biomarkers is imperative to the care of heart failure patients, especially as these newer biomarkers become widely used.",
keywords = "Biomarkers, BNP, Heart failure, Procalcitonin, ST2, Troponin",
author = "Nicholas Wettersten and Maisel, {Alan S.}",
year = "2016",
month = "6",
day = "1",
doi = "10.1016/j.amjmed.2016.01.013",
language = "English (US)",
volume = "129",
pages = "560--567",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Biomarkers for Heart Failure

T2 - An Update for Practitioners of Internal Medicine

AU - Wettersten, Nicholas

AU - Maisel, Alan S.

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Biomarkers have become an integral part of practicing medicine, especially in heart failure. The natriuretic peptides are commonly used in the evaluation of heart failure, but their role extends beyond diagnosis and includes risk stratification and management of heart failure patients. Newer biomarkers have arrived and are becoming part of routine care of heart failure patients. Both ST2 and high-sensitivity troponin have significant prognostic value for mortality, but also may assist in the titration of medical therapy. Procalcitonin can help guide appropriate antibiotic use in patients with heart failure. The ability to appropriately use and interpret these biomarkers is imperative to the care of heart failure patients, especially as these newer biomarkers become widely used.

AB - Biomarkers have become an integral part of practicing medicine, especially in heart failure. The natriuretic peptides are commonly used in the evaluation of heart failure, but their role extends beyond diagnosis and includes risk stratification and management of heart failure patients. Newer biomarkers have arrived and are becoming part of routine care of heart failure patients. Both ST2 and high-sensitivity troponin have significant prognostic value for mortality, but also may assist in the titration of medical therapy. Procalcitonin can help guide appropriate antibiotic use in patients with heart failure. The ability to appropriately use and interpret these biomarkers is imperative to the care of heart failure patients, especially as these newer biomarkers become widely used.

KW - Biomarkers

KW - BNP

KW - Heart failure

KW - Procalcitonin

KW - ST2

KW - Troponin

UR - http://www.scopus.com/inward/record.url?scp=84962574891&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962574891&partnerID=8YFLogxK

U2 - 10.1016/j.amjmed.2016.01.013

DO - 10.1016/j.amjmed.2016.01.013

M3 - Review article

C2 - 26844635

AN - SCOPUS:84962574891

VL - 129

SP - 560

EP - 567

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 6

ER -